Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
Journal of Thrombosis and Thrombolysis · 2024
DOI: 10.1007/s11239-024-02948-5 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Thrombosis and Thrombolysis, 2024. Verfasst von Richard J Buka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. r.j.buka@bham.ac.uk. Hauptthemen laut MEDLINE: Factor Xa Inhibitors, Veterans, Blood Coagulation Factors. Die Arbeit nennt 8 Literaturangaben. Gefördert von: British Heart Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. r.j.buka@bham.ac.uk.
- Staffordshire Thrombosis and Anticoagulation Service, University Hospitals North Midlands NHS Trust, Stoke-on-Trent, UK.
- Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
- Department of Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Förderung
- British Heart Foundation
Zitieren
APA
Buka, R. J., Sutton, D. J., & Nicolson, P. L. (2024). Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-024-02948-5
Vancouver
Buka RJ, Sutton DJ, Nicolson PL. Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate. Journal of Thrombosis and Thrombolysis. 2024. doi:10.1007/s11239-024-02948-5
BibTeX
@article{Buka2024,
author = {Buka, Richard J and Sutton, David J and Nicolson, Phillip Lr},
title = {Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate},
journal = {Journal of Thrombosis and Thrombolysis},
year = {2024},
doi = {10.1007/s11239-024-02948-5}
}
EUVIMED